Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zettl

Showing results (101-110 of 1,084) with videos related to

Pageof 109
Sort By:
Journal of Neurology|September 26, 2006
Intravenous immunoglobulins in neurological diseasesUwe K Zettl, Eilhard Mix
Journal of Neurology|May 16, 2007
Cognitive and neuropsychological disorders in neuroimmunological diseasesUwe K Zettl, Eilhard Mix
Current Pharmaceutical Design|September 21, 2021
Treatment Options in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisordersPaulus Rommer, Uwe K Zettl
Journal of Neurology|September 26, 2006
Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosisAles Dudesek, Uwe K Zettl
Journal of Neurology|September 26, 2006
Intravenous immunoglobulin therapy in neurological diseases during pregnancyIsabel Ringel, Uwe K Zettl
Journal of Neurology|September 26, 2006
Adverse effects of treatment with intravenous immunoglobulins for neurological diseasesMatthias Wittstock, Uwe K Zettl
Frontiers in Neurology|August 15, 2022
The pathophysiology of motor fatigue and fatigability in multiple sclerosisRobert Patejdl, Uwe K Zettl
Autoimmunity Reviews|July 13, 2017
Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventionsRobert Patejdl, Uwe K Zettl
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 18, 2002
The use of multiple sclerosis databases at neurological university hospitals in GermanyM Pette, U K Zettl
Current Pharmaceutical Design|May 23, 2012
Use of intravenous immunoglobulin in the treatment of immune-mediated demyelinating diseases of the nervous systemAlexander Winkelmann, Uwe K Zettl
Pageof 109

Showing results (101-110 of 1,084) with videos related to

Sort By:
Pageof 109
Journal of Neurology|September 26, 2006
Intravenous immunoglobulins in neurological diseasesUwe K Zettl, Eilhard Mix
Journal of Neurology|May 16, 2007
Cognitive and neuropsychological disorders in neuroimmunological diseasesUwe K Zettl, Eilhard Mix
Current Pharmaceutical Design|September 21, 2021
Treatment Options in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisordersPaulus Rommer, Uwe K Zettl
Journal of Neurology|September 26, 2006
Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosisAles Dudesek, Uwe K Zettl
Journal of Neurology|September 26, 2006
Intravenous immunoglobulin therapy in neurological diseases during pregnancyIsabel Ringel, Uwe K Zettl
Journal of Neurology|September 26, 2006
Adverse effects of treatment with intravenous immunoglobulins for neurological diseasesMatthias Wittstock, Uwe K Zettl
Frontiers in Neurology|August 15, 2022
The pathophysiology of motor fatigue and fatigability in multiple sclerosisRobert Patejdl, Uwe K Zettl
Autoimmunity Reviews|July 13, 2017
Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventionsRobert Patejdl, Uwe K Zettl
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 18, 2002
The use of multiple sclerosis databases at neurological university hospitals in GermanyM Pette, U K Zettl
Current Pharmaceutical Design|May 23, 2012
Use of intravenous immunoglobulin in the treatment of immune-mediated demyelinating diseases of the nervous systemAlexander Winkelmann, Uwe K Zettl
Pageof 109